{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:19:12Z","timestamp":1787732352205,"version":"build-2784847793"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["No. C2023201049"],"award-info":[{"award-number":["No. C2023201049"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funding Program for Introducing Overseas Scholars of Hebei Province","award":["No. C20230309"],"award-info":[{"award-number":["No. C20230309"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12602-026-10997-w","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:15:53Z","timestamp":1776327353000},"page":"9145-9156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Probiotics and Bacteriocins Against SARS-CoV-2: Therapeutic Frontiers and Mechanistic Insights"],"prefix":"10.1007","volume":"18","author":[{"given":"Simeng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"7883","key":"10997_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","volume":"599","author":"P Mlcochova","year":"2021","unstructured":"Mlcochova P, Kemp SA, Dhar MS et al (2021) SARS-CoV-2 B.1.617.2 Delta variant replication and immune e-vasion. Nature 599(7883):114\u2013119. https:\/\/doi.org\/10.1038\/s41586-021-03944-y","journal-title":"Nature"},{"key":"10997_CR2","doi-asserted-by":"publisher","first-page":"127204","DOI":"10.1016\/j.micres.2022.127204","volume":"265","author":"R Rana","year":"2022","unstructured":"Rana R, Kant R, Huirem RS et al (2022) Omicron variant: current insights and future directions. Microbiol Res 265:127204. https:\/\/doi.org\/10.1016\/j.micres.2022.127204","journal-title":"Microbiol Res"},{"key":"10997_CR3","doi-asserted-by":"publisher","first-page":"123610","DOI":"10.1016\/j.lfs.2025.123610","volume":"371","author":"M Azeem","year":"2025","unstructured":"Azeem M, Cancemi P, Mukhtar F et al (2025) Efficacy and limitations of SARS-CoV-2 vaccines - A systematic review. Life Sci 371:123610. https:\/\/doi.org\/10.1016\/j.lfs.2025.123610","journal-title":"Life Sci"},{"issue":"2","key":"10997_CR4","doi-asserted-by":"publisher","first-page":"e41980","DOI":"10.1016\/j.heliyon.2025.e41980","volume":"11","author":"S Batool","year":"2025","unstructured":"Batool S, Chokkakula S, Jeong JH et al (2025) SARS-CoV-2 drug resistance and therapeutic approaches. Heliyn 11(2):e41980. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41980","journal-title":"Heliyn"},{"issue":"4","key":"10997_CR5","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s12602-025-10452-2","volume":"17","author":"AN Mafe","year":"2025","unstructured":"Mafe AN, Iruoghene Edo G, Akpoghelie PO et al (2025) Probiotics and food bioactives: unraveling their impact on gut microbiome, inflammation, and metabolic health. Probiotics Antimicrob Proteins 17(4):1851\u20131892. https:\/\/doi.org\/10.1007\/s12602-025-10452-2","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10997_CR6","unstructured":"National Health Commission of the People\u2019s Republic of China, National Administration of Traditional Chinese Medicine (2023) Diagnosis and treatment protocol for novel coronavirus infection (trial version 10) [Internet]. https:\/\/www.gov.cn\/zhengce\/zhengceku\/2023-01\/06\/content_5735343.htm. Accessed 26 Oct 2025"},{"key":"10997_CR7","doi-asserted-by":"publisher","unstructured":"Olaimat AN, Aolymat I, Al-Holy M et al (2020) The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19. npj Sci Food 4(1):17. https:\/\/doi.org\/10.1038\/s41538-020-00078-9","DOI":"10.1038\/s41538-020-00078-9"},{"issue":"9","key":"10997_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41579-024-01045-x","volume":"22","author":"I Sugrue","year":"2024","unstructured":"Sugrue I, Ross RP, Hill C et al (2024) Bacteriocin diversity, function, discovery and application as antimicrobial-s. Nat Rev Microbiol 22(9):556\u2013571. https:\/\/doi.org\/10.1038\/s41579-024-01045-x","journal-title":"Nat Rev Microbiol"},{"key":"10997_CR9","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3389\/fmicb.2020.01877","volume":"11","author":"SK Tiwari","year":"2020","unstructured":"Tiwari SK, Dicks LMT, Popov IV et al (2020) Probiotics at war against viruses: what is missing from the pictur-e? Front Microbiol 11:1877. https:\/\/doi.org\/10.3389\/fmicb.2020.01877","journal-title":"Front Microbiol"},{"issue":"2","key":"10997_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/molecules31020356","volume":"31","author":"B Meskhi","year":"2026","unstructured":"Meskhi B, Todorov SD, Rudoy D et al (2026) Bacteriocins, a new generation of sustainable alternatives to antib-acterial agents in primary food production systems. Molecules 31(2):356. https:\/\/doi.org\/10.3390\/molecules31020356","journal-title":"Molecules"},{"issue":"04","key":"10997_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40249-020-00691-6","volume":"9","author":"XY Zhang","year":"2020","unstructured":"Zhang XY, Huang HJ, Zhuang DL et al (2020) Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Infect Dis Poverty 9(04):10\u201320. https:\/\/doi.org\/10.1186\/s40249-020-00691-6","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"10997_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPR-SS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271\u2013280. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"issue":"3","key":"10997_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00432-021-03843-9","volume":"148","author":"Q Dong","year":"2022","unstructured":"Dong Q, Li Q, Duan L et al (2022) Expressions and significances of CTSL, the target of COVID-19 on GBM. J Cancer Res Clin Oncol 148(3):599\u2013608. https:\/\/doi.org\/10.1007\/s00432-021-03843-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"10997_CR14","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1053\/j.gastro.2020.03.045","volume":"158","author":"M Du","year":"2020","unstructured":"Du M, Cai G, Chen F et al (2020) Multiomics evaluation of gastrointestinal and other clinical characteristics of COVID-19. Gastroenterology 158(8):2298\u20132301 e7. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.045","journal-title":"Gastroenterology"},{"issue":"3","key":"10997_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/cid\/ciaa925","volume":"73","author":"Q Qian","year":"2021","unstructured":"Qian Q, Fan L, Liu W et al (2021) Direct evidence of active SARS-CoV-2 replication in the intestine. Clin Infect Dis 73(3):361\u2013366. https:\/\/doi.org\/10.1093\/cid\/ciaa925","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10997_CR16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/HYPERTENSIONAHA.120.15360","volume":"76","author":"T Yang","year":"2020","unstructured":"Yang T, Chakraborty S, Saha P et al (2020) Gnotobiotic rats reveal that gut microbiota regulates colonic mRNA of Ace2, the receptor for SARS-CoV-2 infectivity. Hypertension 76(1):e1\u2013e3. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15360","journal-title":"Hypertension"},{"key":"10997_CR17","doi-asserted-by":"publisher","first-page":"1274690","DOI":"10.3389\/fcimb.2023.1274690","volume":"13","author":"R Fan","year":"2023","unstructured":"Fan R, Liu S, Sun N et al (2023) Gut microbiota composition is associated with disease severity and host immun-e responses in COVID-19. Front Cell Infect Microbiol 13:1274690. https:\/\/doi.org\/10.3389\/fcimb.2023.1274690","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10997_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jaci.2022.11.007","volume":"151","author":"JK Tan","year":"2023","unstructured":"Tan JK, Macia L, Mackay CR et al (2023) Dietary fiber and SCFAs in the regulation of mucosal immunity. J Al-lergy Clin Immunol 151(2):361\u2013370. https:\/\/doi.org\/10.1016\/j.jaci.2022.11.007","journal-title":"J Al-lergy Clin Immunol"},{"issue":"10223","key":"10997_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel co-ronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"issue":"18","key":"10997_CR20","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W Guan","year":"2020","unstructured":"Guan W, Ni Z, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"issue":"7","key":"10997_CR21","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1136\/gutjnl-2020-321269","volume":"69","author":"MF Neurath","year":"2020","unstructured":"Neurath MF (2020) COVID-19 and immunomodulation in IBD. Gut 69(7):1335\u20131342. https:\/\/doi.org\/10.1136\/gutjnl-2020-321269","journal-title":"Gut"},{"issue":"6","key":"10997_CR22","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/gutjnl-2020-321013","volume":"69","author":"L Lin","year":"2020","unstructured":"Lin L, Jiang X, Zhang Z et al (2020) Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 69(6):997\u20131001. https:\/\/doi.org\/10.1136\/gutjnl-2020-321013","journal-title":"Gut"},{"issue":"6","key":"10997_CR23","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1136\/gutjnl-2020-320926","volume":"69","author":"X Jin","year":"2020","unstructured":"Jin X, Lian JS, Hu JH et al (2020) Epidemiological, clinical and virological characteristics of 74 cases of corona-virus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 69(6):1002\u20131009. https:\/\/doi.org\/10.1136\/gutjnl-2020-320926","journal-title":"Gut"},{"issue":"1","key":"10997_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s43556-022-00103-1","volume":"3","author":"YS Yin","year":"2022","unstructured":"Yin YS, Minacapelli CD, Parmar V et al (2022) Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery. Mol Biomed 3(1):36. https:\/\/doi.org\/10.1186\/s43556-022-00103-1","journal-title":"Mol Biomed"},{"issue":"3","key":"10997_CR25","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1053\/j.gastro.2020.05.048","volume":"159","author":"T Zuo","year":"2020","unstructured":"Zuo T, Zhang F, Lui GCY et al (2020) Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 159(3):944\u2013955 e8. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.048","journal-title":"Gastroenterology"},{"issue":"4","key":"10997_CR26","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","volume":"70","author":"YK Yeoh","year":"2021","unstructured":"Yeoh YK, Zuo T, Lui GC et al (2021) Gut microbiota composition reflects disease severity and dysfunctional i-mmune responses in patients with COVID-19. Gut 70(4):698\u2013706. https:\/\/doi.org\/10.1136\/gutjnl-2020-323020","journal-title":"Gut"},{"issue":"4","key":"10997_CR27","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1053\/j.gastro.2020.06.048","volume":"159","author":"T Zuo","year":"2020","unstructured":"Zuo T, Zhan H, Zhang F et al (2020) Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology 159(4):1302\u20131310 e5. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.048","journal-title":"Gastroenterology"},{"issue":"1","key":"10997_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41421-021-00257-2","volume":"7","author":"H Zhong","year":"2021","unstructured":"Zhong H, Wang Y, Shi Z et al (2021) Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients. Cell Discov 7(1):23. https:\/\/doi.org\/10.1038\/s41421-021-00257-2","journal-title":"Cell Discov"},{"issue":"1","key":"10997_CR29","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1038\/s41467-020-19701-0","volume":"11","author":"KL Bowerman","year":"2020","unstructured":"Bowerman KL, Rehman SF, Vaughan A et al (2020) Disease-associated gut microbiome and metabolome chang-es in patients with chronic obstructive pulmonary disease. Nat Commun 11(1):5886. https:\/\/doi.org\/10.1038\/s41467-020-19701-0","journal-title":"Nat Commun"},{"key":"10997_CR30","doi-asserted-by":"publisher","first-page":"635471","DOI":"10.3389\/fimmu.2021.635471","volume":"12","author":"GLV de Oliveira","year":"2021","unstructured":"de Oliveira GLV, Oliveira CNS, Pinzan CF et al (2021) Microbiota modulation of the gut-lung axis in COVID-19. Front Immunol 12:635471. https:\/\/doi.org\/10.3389\/fimmu.2021.635471","journal-title":"Front Immunol"},{"key":"10997_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41522-021-00262-z","volume":"7","author":"Y Wu","year":"2021","unstructured":"Wu Y, Cheng X, Jiang G et al (2021) Author Correction: Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. npj Biofilms Microbiomes 7:90. https:\/\/doi.org\/10.1038\/s41522-021-00262-z","journal-title":"npj Biofilms Microbiomes"},{"key":"10997_CR32","doi-asserted-by":"publisher","first-page":"752664","DOI":"10.3389\/fcimb.2021.752664","volume":"11","author":"D Belstr\u00f8m","year":"2021","unstructured":"Belstr\u00f8m D, Constancias F, Markvart M et al (2021) Transcriptional activity of predominant Streptococcus spec-ies at multiple oral sites associate with periodontal status. Front Cell Infect Microbiol 11:752664. https:\/\/doi.org\/10.3389\/fcimb.2021.752664","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"10997_CR33","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G et al (2014) Expert consensus document: the international scientific association for pr-obiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gas-troenterol Hepatol 11(8):506\u2013514. https:\/\/doi.org\/10.1038\/nrgastro.2014.66","journal-title":"Nat Rev Gas-troenterol Hepatol"},{"key":"10997_CR34","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3390\/microorganisms9112376","volume":"9","author":"AN Kasti","year":"2021","unstructured":"Kasti AN, Synodinou KD, Pyrousis IA et al (2021) Probiotics regulating inflammation via NLRP3 inflammaso-me modulation: A potential therapeutic approach for COVID-19. Microorganisms 9:2376. https:\/\/doi.org\/10.3390\/microorganisms9112376","journal-title":"Microorganisms"},{"key":"10997_CR35","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3390\/microorganisms10091764","volume":"10","author":"KD Synodinou","year":"2022","unstructured":"Synodinou KD, Nikolaki MD, Triantafyllou K et al (2022) Immunomodulatory effects of probiotics on COVID-19 infection by targeting the gut\u2013lung axis microbial cross-talk. Microorganisms 10:1764. https:\/\/doi.org\/10.3390\/microorganisms10091764","journal-title":"Microorganisms"},{"key":"10997_CR36","doi-asserted-by":"publisher","unstructured":"Ahmadi Badi S, Tarashi S, Fateh A et al (2021) From the role of microbiota in gut-lung axis to SARS-CoV-2 pa-thogenesis. Mediators inflamm 2021: 6611222. https:\/\/doi.org\/10.1155\/2021\/6611222","DOI":"10.1155\/2021\/6611222"},{"issue":"19","key":"10997_CR37","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.3390\/molecules26196076","volume":"26","author":"X Wang","year":"2021","unstructured":"Wang X, Zhang P, Zhang X (2021) Probiotics regulate gut microbiota: an effective method to improve immunity. Molecules 26(19):6076. https:\/\/doi.org\/10.3390\/molecules26196076","journal-title":"Molecules"},{"key":"10997_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12916-021-02212-0","volume":"20","author":"Z Sun","year":"2022","unstructured":"Sun Z, Song ZG, Liu C et al (2022) Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. BMC Med 20:24. https:\/\/doi.org\/10.1186\/s12916-021-02212-0","journal-title":"BMC Med"},{"issue":"11","key":"10997_CR39","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1080\/07391102.2020.1775123","volume":"39","author":"F Anwar","year":"2021","unstructured":"Anwar F, Altayb HN, Al-Abbasi FA et al (2021) Antiviral effects of probiotic metabolites on COVID-19. J Bio-mol Struct Dyn 39(11):4175\u20134184. https:\/\/doi.org\/10.1080\/07391102.2020.1775123","journal-title":"J Bio-mol Struct Dyn"},{"issue":"1","key":"10997_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12602-021-09879-0","volume":"15","author":"I Erol","year":"2023","unstructured":"Erol I, Kotil SE, Fidan O et al (2023) In silico analysis of bacteriocins from lactic acid bacteria against SARS-C-oV-2. Probiotics Antimicrob Proteins 15(1):17\u201329. https:\/\/doi.org\/10.1007\/s12602-021-09879-0","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10997_CR41","doi-asserted-by":"publisher","first-page":"e01603","DOI":"10.1128\/spectrum.01603-24","volume":"12","author":"H Huang","year":"2024","unstructured":"Huang H, Dong X, Du Z et al (2024) Administration of Lactobacillus plantarum GUANKE alleviates SARS-Co-V-2-induced pneumonia in mice. Microbiol Spectr 12:e01603\u2013e01624. https:\/\/doi.org\/10.1128\/spectrum.01603-24","journal-title":"Microbiol Spectr"},{"key":"10997_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12934-023-02100-7","volume":"22","author":"IC Hwang","year":"2023","unstructured":"Hwang IC, Valeriano VD, Song JH et al (2023) Mucosal immunization with Lactiplantibacillus plantarum-disp-laying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in m-ice. Microb Cell Fact 22:96. https:\/\/doi.org\/10.1186\/s12934-023-02100-7","journal-title":"Microb Cell Fact"},{"key":"10997_CR43","doi-asserted-by":"publisher","first-page":"1242681","DOI":"10.3389\/fcimb.2023.1242681","volume":"13","author":"IC Hwang","year":"2023","unstructured":"Hwang IC, Vasquez R, Song JH et al (2023) Alterations in the gut microbiome and its metabolites are associated with the immune response to mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 spike epitopes in mice. Front Cell Infect Microbiol 13:1242681. https:\/\/doi.org\/10.3389\/fcimb.2023.1242681","journal-title":"Front Cell Infect Microbiol"},{"key":"10997_CR44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fmed.2020.00389","volume":"7","author":"G d\u2019Ettorre","year":"2020","unstructured":"d\u2019Ettorre G, Ceccarelli G, Marazzato M et al (2020) Challenges in the management of SARS-CoV2 infection: the role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19. Front Med (Lausanne) 7:389. https:\/\/doi.org\/10.3389\/fmed.2020.00389","journal-title":"Front Med (Lausanne)"},{"key":"10997_CR45","doi-asserted-by":"publisher","first-page":"175628482110356","DOI":"10.1177\/17562848211035670","volume":"14","author":"L Zhang","year":"2021","unstructured":"Zhang L, Han H, Li X et al (2021) Probiotics use is associated with improved clinical outcomes among hospitali-zed patients with COVID-19. Th Adv Gastroenterol 14:17562848211035670. https:\/\/doi.org\/10.1177\/17562848211035670","journal-title":"Th Adv Gastroenterol"},{"issue":"3","key":"10997_CR46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1473-3099(23)00685-0","volume":"24","author":"RI Lau","year":"2024","unstructured":"Lau RI, Su Q, Lau ISF et al (2024) A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hon-g Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 24(3):256\u2013265. https:\/\/doi.org\/10.1016\/S1473-3099(23)00685-0","journal-title":"Lancet Infect Dis"},{"key":"10997_CR47","doi-asserted-by":"publisher","first-page":"1179432","DOI":"10.3389\/fnut.2023.1179432","volume":"10","author":"Y Tian","year":"2023","unstructured":"Tian Y, Ran H, Wen X et al (2023) Probiotics improve symptoms of patients with COVID-19 through gut-lung axis: a systematic review and meta-analysis. Front Nutr 10:1179432. https:\/\/doi.org\/10.3389\/fnut.2023.1179432","journal-title":"Front Nutr"},{"issue":"1","key":"10997_CR48","doi-asserted-by":"publisher","first-page":"2018899","DOI":"10.1080\/19490976.2021.2018899","volume":"14","author":"P Guti\u00e9rrez-Castrell\u00f3n","year":"2022","unstructured":"Guti\u00e9rrez-Castrell\u00f3n P, Gandara-Mart\u00ed T, Abreu Y, Abreu AT et al (2022) Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes 14(1):2018899. https:\/\/doi.org\/10.1080\/19490976.2021.2018899","journal-title":"Gut Microbes"},{"key":"10997_CR49","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/nu16091339","volume":"16","author":"GH Hong","year":"2024","unstructured":"Hong GH, Lee SY, Kim IA et al (2024) Effect of heat-treated Lactiplantibacillus plantarum nF1 on the immune system including natural killer cell activity: a randomized, placebo-controlled, double-blind study. Nutrients 16:1339. https:\/\/doi.org\/10.3390\/nu16091339","journal-title":"Nutrients"},{"key":"10997_CR50","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1007\/s40121-025-01246-8","volume":"14","author":"K Yamamoto","year":"2025","unstructured":"Yamamoto K, Inoue T, Ikeda T et al (2025) Efficacy of Lactococcus lactis strain plasma in patients with mild C-OVID-19: a multicenter, double-blinded, randomized-controlled trial (PLATEAU study). Infect Dis Ther 14:2835\u20132285. https:\/\/doi.org\/10.1007\/s40121-025-01246-8","journal-title":"Infect Dis Ther"},{"key":"10997_CR51","doi-asserted-by":"publisher","first-page":"613928","DOI":"10.3389\/fnut.2020.613928","volume":"7","author":"G Ceccarelli","year":"2021","unstructured":"Ceccarelli G, Borrazzo C, Pinacchio C et al (2021) Oral bacteriotherapy in patients with COVID-19: a retrospec-tive cohort study. Front Nutr 7:613928. https:\/\/doi.org\/10.3389\/fnut.2020.613928","journal-title":"Front Nutr"},{"issue":"7","key":"10997_CR52","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1007\/s00253-016-7343-9","volume":"100","author":"P Alvarez-Sieiro","year":"2016","unstructured":"Alvarez-Sieiro P, Montalb\u00e1n-L\u00f3pez M, Mu D et al (2016) Bacteriocins of lactic acid bacteria: extending the fam-ily. Appl Microbiol Biotechnol 100(7):2939\u20132951. https:\/\/doi.org\/10.1007\/s00253-016-7343-9","journal-title":"Appl Microbiol Biotechnol"},{"key":"10997_CR53","doi-asserted-by":"publisher","unstructured":"Xavier-Santos D, Padilha M, Fabiano GA et al (2022) Corrigendum to 'Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bi-bliometric analysis and integrative review' [Trends in Food Science & Technology 120 (2022) 174-192]. Trends Food Sci. Technol 121: 156\u2013160. https:\/\/doi.org\/10.1016\/j.tifs.2022.01.028","DOI":"10.1016\/j.tifs.2022.01.028"},{"key":"10997_CR54","doi-asserted-by":"publisher","unstructured":"Rather IA, Lew LC, Kamli MR et al (2022) The inhibition of SARS-CoV-2 and the modulation of inflammatory responses by the extract of Lactobacillus sakei Probio65. Vaccines 10(12): 2106. https:\/\/doi.org\/10.3390\/vaccines10122106","DOI":"10.3390\/vaccines10122106"},{"issue":"10","key":"10997_CR55","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3390\/vaccines10101581","volume":"10","author":"OR Alzahrani","year":"2022","unstructured":"Alzahrani OR, Hawsawi YM, Alanazi AD et al (2022) In vitro evaluation of Leuconostoc mesenteroides cell-fre-e-supernatant GBUT-21 against SARS-CoV-2. Vaccines 10(10):1581. https:\/\/doi.org\/10.3390\/vaccines10101581","journal-title":"Vaccines"},{"issue":"9","key":"10997_CR56","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3390\/pathogens10091197","volume":"10","author":"MA Islam","year":"2021","unstructured":"Islam MA, Albarracin L, Tomokiyo M et al (2021) Immunobiotic lactobacilli improve resistance of respiratory epithelial cells to SARS-CoV-2 infection. Pathogens 10(9):1197. https:\/\/doi.org\/10.3390\/pathogens10091197","journal-title":"Pathogens"},{"key":"10997_CR57","doi-asserted-by":"publisher","first-page":"10079","DOI":"10.3390\/ijms262010079","volume":"26","author":"L Arellano-Arriagada","year":"2025","unstructured":"Arellano-Arriagada L, Albarracin L, Fukuyama K et al (2025) Combined Lactiplantibacillus plantarum CRL1506 and MPL16 nasal priming more effectively modulates respiratory antiviral innate immunity than single strains. Int J Mol Sci 26:10079. https:\/\/doi.org\/10.3390\/ijms262010079","journal-title":"Int J Mol Sci"},{"key":"10997_CR58","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12985-025-02921-5","volume":"22","author":"BC English","year":"2025","unstructured":"English BC, Radaic A, Barrios-Medina R et al (2025) The antimicrobial peptide nisin promotes host cell survival during SARS-CoV-2 infection. Virol J 22:316. https:\/\/doi.org\/10.1186\/s12985-025-02921-5","journal-title":"Virol J"},{"issue":"1","key":"10997_CR59","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12974-023-02915-6","volume":"20","author":"C Zhao","year":"2023","unstructured":"Zhao C, Kuraji R, Ye C et al (2023) Nisin a probiotic bacteriocin mitigates brain microbiome dysbiosis and alz-heimer\u2019s disease-like neuroinflammation triggered by periodontal disease. J Neuroinflammation 20(1):228. https:\/\/doi.org\/10.1186\/s12974-023-02915-6","journal-title":"J Neuroinflammation"},{"key":"10997_CR60","doi-asserted-by":"publisher","first-page":"170479","DOI":"10.1016\/j.peptides.2020.170479","volume":"137","author":"J Ma\u0142aczewska","year":"2021","unstructured":"Ma\u0142aczewska J, Kaczorek-\u0141ukowska E (2021) Nisin\u2014A Lantibiotic with immunomodulatory properties: a revi-ew. Peptides 137:170479. https:\/\/doi.org\/10.1016\/j.peptides.2020.170479","journal-title":"Peptides"},{"issue":"3","key":"10997_CR61","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s12602-020-09727-7","volume":"13","author":"S Manna","year":"2021","unstructured":"Manna S, Chowdhury T, Chakraborty R et al (2021) Probiotics-derived peptides and their immunomodulatory molecules can play a preventive role against viral diseases including COVID-19. Probiotics Antimicrob Proteins 13(3):611\u2013623. https:\/\/doi.org\/10.1007\/s12602-020-09727-7","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"20","key":"10997_CR62","doi-asserted-by":"publisher","first-page":"10774","DOI":"10.1080\/07391102.2022.2158934","volume":"41","author":"I Erol","year":"2023","unstructured":"Erol I, Kotil SE, Ortakci F et al (2023) Exploring the binding capacity of lactic acid bacteria derived bacteriocins against RBD of SARS-CoV-2 Omicron variant by molecular simulations. J Biomol Struct Dyn 41(20):10774\u201310784. https:\/\/doi.org\/10.1080\/07391102.2022.2158934","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"10997_CR63","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1080\/07391102.2023.2292307","volume":"43","author":"F Abedi Dorcheh","year":"2025","unstructured":"Abedi Dorcheh F, Balmeh N, Hejazi SH et al (2025) Investigation of the mutated antimicrobial peptides to inhib-it ACE2, TMPRSS2 and GRP78 receptors of SARS-CoV-2 and angiotensin II type 1 receptor (AT1R) as well as controlling COVID-19 disease. J Biomol Struct Dyn 43(4):1641\u20131664. https:\/\/doi.org\/10.1080\/07391102.2023.2292307","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10997_CR64","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41392-021-00551-1","volume":"6","author":"R Zhang","year":"2021","unstructured":"Zhang R, Jiang X, Qiao J et al (2021) Antimicrobial peptide DP7 with potential activity against SARS coronavir-us infections. Signal Transduct Target Ther 6(1):140. https:\/\/doi.org\/10.1038\/s41392-021-00551-1","journal-title":"Signal Transduct Target Ther"},{"key":"10997_CR65","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00203-024-04002-7","volume":"206","author":"R Teiar","year":"2024","unstructured":"Teiar R, Sane F, Erol I et al (2024) Enterocin DD14 can inhibit the infection of eukaryotic cells with enveloped viruses. Arch Microbiol 206:269. https:\/\/doi.org\/10.1007\/s00203-024-04002-7","journal-title":"Arch Microbiol"},{"issue":"17","key":"10997_CR66","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.7150\/thno.47987","volume":"10","author":"X Liu","year":"2020","unstructured":"Liu X, Liu C, Liu G et al (2020) COVID-19: Progress in diagnostics, therapy and vaccination. Theranostics 10(17):7821. https:\/\/doi.org\/10.7150\/thno.47987","journal-title":"Theranostics"},{"issue":"4","key":"10997_CR67","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.virs.2025.07.002","volume":"40","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ji X, Huang D et al (2025) The coronavirus 3CL protease: Unveiling its complex host interactions and central role in viral pathogenesis. Virol Sin 40(4):509\u2013519. https:\/\/doi.org\/10.1016\/j.virs.2025.07.002","journal-title":"Virol Sin"},{"issue":"17","key":"10997_CR68","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1111\/febs.15696","volume":"288","author":"CC Chen","year":"2021","unstructured":"Chen CC, Yu X, Kuo CJ et al (2021) Overview of antiviral drug candidates targeting coronaviral 3\u00a0C-like main p-roteases. FEBS J 288(17):5089\u20135121. https:\/\/doi.org\/10.1111\/febs.15696","journal-title":"FEBS J"},{"key":"10997_CR69","doi-asserted-by":"publisher","unstructured":"Hu Q, Xiong Y, Zhu GH et al (2022) The SARS-CoV\u20102 main protease (Mpro): Structure, function, and emerging therapies for COVID\u201019. MedComm 3(3): e151. https:\/\/doi.org\/10.1002\/mco2.151","DOI":"10.1002\/mco2.151"},{"key":"10997_CR70","doi-asserted-by":"publisher","first-page":"100515","DOI":"10.1016\/j.imu.2021.100515","volume":"23","author":"N Balmeh","year":"2021","unstructured":"Balmeh N, Mahmoudi S, Fard NA (2021) Manipulated bio antimicrobial peptides from probiotic bacteria as pro-posed drugs for COVID-19 disease. Inf Med Unlocked 23:100515. https:\/\/doi.org\/10.1016\/j.imu.2021.100515","journal-title":"Inf Med Unlocked"},{"issue":"10","key":"10997_CR71","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/vaccines9101067","volume":"9","author":"IA Rather","year":"2021","unstructured":"Rather IA, Choi SB, Kamli MR et al (2021) Potential adjuvant therapeutic effect of Lactobacillus plantarum Pr-obio-88 postbiotics against SARS-COV-2. Vaccines 9(10):1067. https:\/\/doi.org\/10.3390\/vaccines9101067","journal-title":"Vaccines"},{"issue":"3","key":"10997_CR72","doi-asserted-by":"publisher","first-page":"e2431","DOI":"10.1002\/rmv.2431","volume":"33","author":"F Maghsood","year":"2023","unstructured":"Maghsood F, Ghorbani A, Yadegari H et al (2023) SARS-CoV\u20102 nucleocapsid: Biological functions and implic-ation for disease diagnosis and vaccine design. Rev Med Virol 33(3):e2431. https:\/\/doi.org\/10.1002\/rmv.2431","journal-title":"Rev Med Virol"},{"key":"10997_CR73","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3390\/antibiotics12071188","volume":"12","author":"R Ladjouzi","year":"2023","unstructured":"Ladjouzi R, Dussert E, Teiar R (2023) A review on Enterocin DD14, the leaderless two-peptide bacteriocin with multiple biological functions and unusual transport pathway. Antibiotics 12:1188. https:\/\/doi.org\/10.3390\/antibiotics12071188","journal-title":"Antibiotics"},{"key":"10997_CR74","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12866-024-03400-7","volume":"24","author":"M Derakhshan-sefidi","year":"2024","unstructured":"Derakhshan-sefidi M, Bakhshi B, Rasekhi A (2024) Thiolated chitosan nanoparticles encapsulated nisin and sel-enium: antimicrobial\/antibiofilm\/anti-attachment\/immunomodulatory multi-functional agent. BMC Microbiol 24:257. https:\/\/doi.org\/10.1186\/s12866-024-03400-7","journal-title":"BMC Microbiol"},{"issue":"2","key":"10997_CR75","doi-asserted-by":"publisher","first-page":"38","DOI":"10.26502\/acmcr.96550707","volume":"9","author":"P Kamarajan","year":"2025","unstructured":"Kamarajan P, Kassem A, Radaic A et al (2025) Case of nisin oral ingestion and its LC-MS\/MS detection in hu-man urine over time: a case report. Arch Clin Med Case Rep 9(2):38\u201345. https:\/\/doi.org\/10.26502\/acmcr.96550707","journal-title":"Arch Clin Med Case Rep"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-10997-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-10997-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-10997-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:30:50Z","timestamp":1787729450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-10997-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":75,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10997"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-10997-w","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study involved no experimentation with human subjects. No applicability.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare their consent to participate in this article.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare their consent to publish in this article.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}